Posaconazole as salvage therapy for zygomycosis. - sprookjes - yvandenbroek - TriplyDB

Posaconazole as salvage therapy for zygomycosis.

Posaconazole as salvage therapy for zygomycosis.

http://www.wikidata.org/entity/Q34301611

about

Mucormycosis, pseudallescheriasis, and other uncommon mold infections Recent advances in the management of mucormycosis: from bench to bedside Role of isavuconazole in the treatment of invasive fungal infections Therapeutic Drug Monitoring of Posaconazole: an Update Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections Invasive mold infections in solid organ transplant recipients Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent Posaconazole: an oral triazole with an extended spectrum of activity Absidia Corymbifera in an immune competent accident victim with multiple abdominal injuries: case report.Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): a taxonomic update and review of the literature.ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.Antifungal susceptibility profile of human-pathogenic species of Lichtheimia Recent advances in the treatment of mucormycosis.Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.Drug strategies targeting CYP51 in neglected tropical diseases In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.Management of neonatal candidiasis. Neonatal Candidiasis Study Group Combat-Related Invasive Fungal Wound Infections Zygomycosis in Immunocompromised non-Haematological Patients.How should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review.Human Fungal Pathogens of Mucorales and Entomophthorales.Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer.Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009 Etest cannot be recommended for in vitro susceptibility testing of mucorales.Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.Carbon assimilation profiles as a tool for identification of zygomycetes How I treat mucormycosis.A review of clinical experience with newer antifungals in children Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.Emerging echinocandins for treatment of invasive fungal infections.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.Invasive fungal infections in acute leukemia.Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.Posaconazole: a new broad-spectrum antifungal agent.

P2860

Q24603297-A79F2AD3-097F-4451-B097-8F88D7181A4A Q24642450-156BBC7C-0ABB-4386-B799-3568AAF79EF4 Q26740837-A7B750C4-83FB-40E4-8708-A855975BB6D0 Q26746016-56A336DE-9A93-413D-A66B-07671F11B8B4 Q26771180-6B90566C-2F4A-4FD4-BB2C-76463770E570 Q26823811-82775069-9A6F-428A-AF54-ABA963C7C78D Q26860727-0DCCB6F6-4A28-4CC5-AE91-FD416ACEC705 Q28082019-B365ECF1-681C-4140-814F-49201CE0AB2B Q28291282-48F0AA40-9118-4ACF-B869-EBDD1860D035 Q33285897-713CE74E-47F9-482C-AA06-4DD195A2428D Q33514740-AB315B38-0A5F-4788-B502-366B55D1E112 Q33573788-F9F8DBA7-6193-4666-B6A4-C5C8C47DA550 Q33644747-F37EDF9F-D0B3-46C9-B282-B3F3A531B390 Q33826450-13853336-7154-4859-9EC9-887F9F11DACD Q33962824-AA96C182-CD8E-42E7-98F1-614498A923A6 Q34161213-3BEF6A35-C813-4780-BC39-13CFD5F6053F Q34498982-0C97287C-F911-4937-A5D9-78D7FC048BA8 Q34622554-876C97D3-0F81-4466-A2C9-177863257E9C Q34680661-803175F8-287E-4E7A-8884-CC3E5DF9BFB1 Q34680771-C85B90EA-4E30-4931-8D9C-728543365CC2 Q34708588-B5AF52F2-92BE-421E-A4E0-299F3366ED0E Q35010681-EAEC4AF9-5455-4315-B3FD-12FEB26DC36C Q35196776-5EABC5B6-7B43-4196-8C05-CADA51C6FCD4 Q35245238-E8D0A1DD-656D-424B-A4C7-3B61FBDD5C02 Q35262607-04AEB3D0-D541-41BA-A43A-7D014C207971 Q35364288-7E1D91B5-EF28-44B7-9D10-9A71841DD83C Q35595623-51168649-91A0-4324-8996-E322519DC9E1 Q35668229-EFC1A1E7-3788-4979-BD8D-652721F846B6 Q35784447-80638EE4-1B6B-4912-9A3A-14364EE4E606 Q35797637-A4AA4A23-3B49-46CA-9E40-422D825F002C Q36290698-03F82250-623D-434D-971F-15AA6EDB3C03 Q36424973-3594AD87-AB44-46FA-A444-CBB12B131D61 Q36458402-22044DF3-7F94-4249-8244-48335C036DBE Q36521993-71129531-C71D-48E1-BB3A-5A852FEB3711 Q36568458-0CFF32D7-87EC-4316-BE4B-081E403BC90A Q36589297-E0F429A2-AE39-4791-B539-154AA1B08845 Q36597431-7C445D2E-8F0F-4E58-BDDD-24323A45127B Q36612597-9DA865FA-ED7D-414F-A55C-8488A6FE0CC3 Q36718486-679006AE-F6B1-4DB0-8FFF-A1A87286A6BA Q36828159-8ACA33AD-F234-4108-A05F-532B4B89026C

P2860

Posaconazole as salvage therapy for zygomycosis.

http://www.wikidata.org/entity/Q34301611

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Posaconazole as salvage therapy for zygomycosis.

@ast

Posaconazole as salvage therapy for zygomycosis.

@en

Posaconazole as salvage therapy for zygomycosis.

@nl

type

label

Posaconazole as salvage therapy for zygomycosis.

@ast

Posaconazole as salvage therapy for zygomycosis.

@en

Posaconazole as salvage therapy for zygomycosis.

@nl

prefLabel

Posaconazole as salvage therapy for zygomycosis.

@ast

Posaconazole as salvage therapy for zygomycosis.

@en

Posaconazole as salvage therapy for zygomycosis.

@nl

P1433

Q34301611-861C0442-3CCD-4F08-9FDA-56D6DEAAAF19

P1476

Q34301611-F394967A-2F3A-416A-B7E9-A28B9146E8F7

P2093

Q34301611-12062ECD-230D-4B9F-9215-36F486B9D3D1

Q34301611-2556E05E-74A7-4203-AD43-D1927EEDD521

Q34301611-37261D4D-9764-44E9-8A3B-510F37850853

Q34301611-3E6CA00C-1EE4-4AB1-A84F-BB42460E1BC5

Q34301611-43AC7EF9-F8F7-490D-B575-658A97C3AD20

Q34301611-53F5C4D3-B407-47CD-AC41-CF67D4FCBCB7

Q34301611-795AB3E7-A4E2-4AAD-A0B7-1A94A94E00FB

Q34301611-91D7B3FB-058C-45C9-9C6B-29FEB12C944A

Q34301611-9EDF9940-3F89-412B-89A2-F8D95C511A4D

Q34301611-B2745BD8-8CF6-42C9-9D43-D9B4EE7CF5AF

P2860

Q34301611-02A72552-3134-48A7-8318-DB82A35CD433

Q34301611-096939B6-4C2C-46F0-9216-74D20F378B60

Q34301611-0A006BE9-B098-444D-AC3C-57C52112A7E0

Q34301611-14B79044-4AA3-4C75-9D7E-57DC16BD008A

Q34301611-1D7ED4D3-36DE-4E0B-B5F2-3ADFBEB41B07

Q34301611-21648DCE-0600-4BCF-AFA3-BB9ADFC36548

Q34301611-2C790090-7D33-4781-9E53-B411A547977D

Q34301611-2DB6AFD6-FD0C-44E2-B361-E078884F4467

Q34301611-37309385-7E7F-49F8-9263-933F633181C7

Q34301611-3CA8C94E-1A96-47D8-ADE7-19BC1F2F357B

P304

Q34301611-08C11990-2A63-45C6-9F9D-2F1D370814E9

P31

Q34301611-B6D0D2D0-D860-458B-8B17-FBBE960FCAEB

P356

Q34301611-EEBE3257-14F0-447B-9296-845520785C3E

P407

Q34301611-A8ECF9DF-AEC3-4B10-84B7-B178C954C62D

P433

Q34301611-31BBCEEF-AE27-4FA7-B752-501D88A05205

P478

Q34301611-04303231-2C11-4257-8C3F-A07D25419A02

P50

Q34301611-BF1EE38D-7D7D-436F-B8C6-4F241E67522E

P577

Q34301611-1B2F1857-5D09-4DD6-8ED1-D9158C877EE3

P5875

Q34301611-F1E5D542-1BFD-4E3B-824E-31F609AAAD65

P698

Q34301611-3267DD7E-2820-443D-8051-F9D7723D3E72

P932

Q34301611-59425F50-23EC-4C1B-B20A-33EBBD6569C7

P356

AAC.50.1.126-133.2006

P1433

Antimicrobial Agents and Chemotherapy

P1476

Posaconazole as salvage therapy for zygomycosis.

@en

P2093

A Langston

http://www.w3.org/2001/XMLSchema#string

C E Gonzalez

http://www.w3.org/2001/XMLSchema#string

G Anstead

http://www.w3.org/2001/XMLSchema#string

G Corcoran

http://www.w3.org/2001/XMLSchema#string

G Schiller

http://www.w3.org/2001/XMLSchema#string

I Raad

http://www.w3.org/2001/XMLSchema#string

J R Wingard

http://www.w3.org/2001/XMLSchema#string

J-A H van Burik

http://www.w3.org/2001/XMLSchema#string

K A Marr

http://www.w3.org/2001/XMLSchema#string

K Mullane

http://www.w3.org/2001/XMLSchema#string

P2860

Zygomycetes in human disease

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

Pulmonary mucormycosis: the last 30 years.

Rhinocerebral mucormycosis in patients with burns: case report and review of the literature.

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis.

Infections in patients with diabetes mellitus.

Disseminated zygomycosis due to Rhizopus schipperae after heatstroke.

Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology.

Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

P304

126-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.50.1.126-133.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Raoul Herbrecht

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7393011

http://www.w3.org/2001/XMLSchema#string

P698

16377677

http://www.w3.org/2001/XMLSchema#string

P932

1346806

http://www.w3.org/2001/XMLSchema#string